42 Risk of Potentially Preventable Hospitalizations After COVID-19 Infection Among US Veterans

MEIKE NIEDERHAUSEN Co-Author
Oregon Health & Science University
 
Yumie Takata Co-Author
College of Health, Oregon State University
 
Alex Hickok Co-Author
 
Mazhgan Rowneki Co-Author
Department of Veterans Affairs
 
Holly McCready Co-Author
Center to Improve Veteran Involvement in Care, VA Portland Health Care System
 
Valerie Smith Co-Author
Duke University
 
Thomas Osborne Co-Author
VA Palo Alto Health Care System
 
Edward Boyko Co-Author
VA Puget Sound Health Care System
 
George Ioannou Co-Author
VA Puget Sound Health Care System
 
Matthew Maciejewski Co-Author
VA Durham Health Care System
 
Elizabeth Viglianti Co-Author
VA Ann Arbor Health Care System
 
Amy Bohnert Co-Author
VA Ann Arbor Health Care System
 
Ann O'Hare Co-Author
VA Puget Sound Health Care System
 
Theodore Iwashyna Co-Author
Johns Hopkins University
 
Denise Hynes Co-Author
Center to Improve Veteran Involvement in Care, VA Portland Health Care System
 
Diana Govier First Author
Center to Improve Veteran Involvement in Care, VA Portland Health Care System, Portland, OR
 
Alex Hickok Presenting Author
 
Tuesday, Aug 6: 10:30 AM - 12:20 PM
3614 
Contributed Posters 
Oregon Convention Center 
Potentially preventable hospitalizations (PPH) are used to measure health system performance. During the COVID-19 pandemic, disruptions to healthcare may have hindered disease treatment and increased the risk of PPH. Messaging to stay home when sick, as well as post-infection sequelae may have compounded risks among those with COVID-19. Using an emulated target trial design with monthly sequential trials, we compared risk of a PPH among 189,136 Veterans with COVID-19 between March 1, 2020, and April 30, 2021 and 943,084 matched uninfected comparators. The primary outcome was a first PPH in Veterans Health Administration (VHA) hospitals, or in community hospitals either paid by VHA or Medicare fee-for-service. Extended Cox models were used to examine adjusted hazard ratios (aHRs) of PPH among Veterans with COVID-19 and comparators during varying follow-up periods: 0-30, 0-90, 0-180, and 0-365 days. In total, 3.1% (3.8% of infected and 3.0% of comparators) of Veterans had a PPH during one-year follow-up. The risk of a PPH was greater among Veterans with COVID-19 than comparators in four follow-up periods: 0-30-day aHR=3.26; 0-90-day aHR=2.12; 0-180-day aHR=1.69; 0-395-day aHR=1.44.

Keywords

emulated target trial

preventable hospitalization

extended Cox modelling

SARS-CoV-2

COVID-19

Veterans 

Abstracts


Main Sponsor

Section on Statistics in Epidemiology